You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Ontak

Showing 1 - 25 of 36
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Epithelial Ovarian Cancer Trial in Pittsburgh (Pembrolizumab, E7777)

Not yet recruiting
  • Epithelial Ovarian Cancer
  • Pittsburgh, Pennsylvania
    UPMC Hillman Cancer Center
Aug 4, 2022

Melanoma Trial in Chicago (4-peptide melanoma vaccine, Ontak)

Terminated
Has Results
  • Melanoma
  • 4-peptide melanoma vaccine
  • Ontak
  • Chicago, Illinois
    University of Chicago
Jan 6, 2021

GVHD, Immune System Disorders Trial in United States (Etanercept, Mycophenolate Mofetil, Denileukin Diftitox)

Completed
Has Results
  • Graft vs Host Disease
  • Immune System Disorders
  • Duarte, California
  • +18 more
Oct 19, 2021

Peripheral T-Cell Lymphoma Trial in Saint Louis (Gemcitabine, Navelbine, Doxorubicin Hydrochloride Liposome Injection)

Terminated
Has Results
  • Peripheral T-Cell Lymphoma
  • Saint Louis, Missouri
    Washington University
Apr 14, 2020

Leukemia, Adult T-Cell Trial run by the NCI (Denileukin diftitox (Ontak))

Terminated
Has Results
  • Leukemia, Adult T-Cell
  • Denileukin diftitox (Ontak)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Nov 8, 2019

Male Breast Cancer, Recurrent Breast Cancer, Stage IIIA Breast Cancer Trial in Seattle (biological, other, genetic)

Completed
Has Results
  • Male Breast Cancer
  • +5 more
  • ONTAK
  • +5 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 9, 2018

Fallopian Tube Cancer, Ovarian Clear Cell Cystadenocarcinoma, Ovarian Endometrioid Adenocarcinoma Trial in Seattle (biological,

Completed
  • Fallopian Tube Cancer
  • +10 more
  • denileukin diftitox
  • +4 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
May 13, 2019

Epithelial Ovarian Cancer, Extraovarian Peritoneal Cancer, Fallopian Tube Carcinoma Trial in San Antonio (Ontak)

Completed
Has Results
  • Epithelial Ovarian Cancer
  • +2 more
  • Ontak
  • San Antonio, Texas
    CTRC at UTHSCSA
Feb 27, 2018

Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Minneapolis (Rituximab, Interleukin-2, Natural killer cells)

Completed
Has Results
  • Non-Hodgkin Lymphoma
  • Chronic Lymphocytic Leukemia
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Jan 10, 2018

Melanoma (Skin) Trial in Erlangen (Dendritic cell vaccine plus denileukin difitox)

Completed
  • Melanoma (Skin)
  • Dendritic cell vaccine plus denileukin difitox
  • Erlangen, Germany
    Dermatologische Klinik mit Poliklinik - Universitaetsklinikum Er
Feb 16, 2018

Epithelial Ovarian Cancer, Extraovarian Peritoneal Cancer, Fallopian Tube Carcinoma Trial in San Antonio (Denileukin Diftitox/SC

Terminated
Has Results
  • Epithelial Ovarian Cancer
  • +2 more
  • Denileukin Diftitox/SC Pegylated IFNα-2a
  • San Antonio, Texas
    CTRC (Cancer Therapy and Research Center) at UTHSCSA
Mar 13, 2018

Leukemia, Myelogenous, Acute Trial in Minneapolis (biological, drug, procedure)

Terminated
Has Results
  • Leukemia, Myelogenous, Acute
  • Natural Killer Cells
  • +5 more
  • Minneapolis, Minnesota
    Masonic Cancer Center, University of Minnesota
Dec 3, 2017

Multiple Myeloma Trial in Detroit (Denileukin Diftitox (Ontak))

Terminated
Has Results
  • Multiple Myeloma
  • Denileukin Diftitox (Ontak)
  • Detroit, Michigan
    Barbara Ann Karmanos Cancer Institute
May 26, 2017

Stage IIIC Melanoma, Stage IV Melanoma Trial in United States (Denileukin diftitox)

Completed
  • Stage IIIC Melanoma
  • Stage IV Melanoma
  • Denileukin diftitox
  • Encinitas, California
  • +9 more
Feb 28, 2019

Non-infectious Intermediate and Posterior Uveitis Trial run by the NEI (Daclizumab)

Completed
  • Non-infectious Intermediate and Posterior Uveitis
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 30, 2017

Metastatic Pancreatic Cancer Trial in Maywood (Ontak)

Terminated
Has Results
  • Metastatic Pancreatic Cancer
  • Ontak
  • Maywood, Illinois
    Loyola Univeristy Medical Center, Cardinal Bernardin Cancer Cent
Aug 23, 2016

Leukemia Trial in United States (denileukin diftitox)

Completed
  • Leukemia
  • denileukin diftitox
  • Orange, California
  • +10 more
Jan 17, 2017

Lymphoma Trial in Miami (biological, drug, genetic, other)

Withdrawn
  • Lymphoma
  • denileukin diftitox
  • +10 more
  • Miami, Florida
    University of Miami Sylvester Comprehensive Cancer Center - Miam
Dec 14, 2016

Cancer Trial (Denileukin diftitox (ONTAK))

No longer available
  • Cancer
  • Denileukin diftitox (ONTAK)
  • (no location specified)
Jan 22, 2015

Peripheral T-Cell Lymphoma Trial in New Haven (Ontak, CHOP (cyclophosphamide (C), adriamycin (H), vincristine (O), and

Completed
Has Results
  • Peripheral T-Cell Lymphoma
  • Ontak
  • CHOP (cyclophosphamide (C), adriamycin (H), vincristine (O), and prednisone (P)) chemotherapy
  • New Haven, Connecticut
    Yale Comprehensive Cancer Center at Yale University School of Me
Feb 9, 2015

Malignant Melanoma Trial in Louisville (Denileukin diftitox)

Completed
Has Results
  • Malignant Melanoma
  • Denileukin diftitox
  • Louisville, Kentucky
    James Graham Brown Cancer Center, Univ. of Louisville
Aug 26, 2014

Bone Marrow Transplantation, Blood Disease, Hematopoietic Stem Cell Transplantation Trial in United States (fluconazole,

Completed
  • Bone Marrow Transplantation
  • +6 more
  • Duarte, California
  • +15 more
Feb 17, 2016

HER2-positive Breast Cancer, Recurrent Breast Cancer, Recurrent NSCLC Trial in Seattle (drug, biological, other)

Completed
  • HER2-positive Breast Cancer
  • +8 more
  • ex vivo-expanded HER2-specific T cells
  • +4 more
  • Seattle, Washington
    Fred Hutchinson Cancer Research Center/University of Washington
Nov 7, 2014

Leukemia, Lymphoma Trial in United States (denileukin diftitox)

Unknown status
  • Leukemia
  • Lymphoma
  • denileukin diftitox
  • Pomona, California
  • +5 more
Dec 17, 2013

Anaplastic Large-Cell Lymphoma Trial in New York (Denileukin Diftitox, Denileukin diftitox, ifosfamide, cyclophosphamide,

Withdrawn
  • Anaplastic Large-Cell Lymphoma
  • Denileukin Diftitox
  • Denileukin diftitox, ifosfamide, cyclophosphamide, etoposide
  • New York, New York
    Columbia University Medical Center
May 14, 2013